These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 10766889)

  • 1. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation.
    Bejjani BP; Gervais D; Arnulf I; Papadopoulos S; Demeret S; Bonnet AM; Cornu P; Damier P; Agid Y
    J Neurol Neurosurg Psychiatry; 2000 May; 68(5):595-600. PubMed ID: 10766889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
    Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T
    J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical predictive factors of subthalamic stimulation in Parkinson's disease.
    Welter ML; Houeto JL; Tezenas du Montcel S; Mesnage V; Bonnet AM; Pillon B; Arnulf I; Pidoux B; Dormont D; Cornu P; Agid Y
    Brain; 2002 Mar; 125(Pt 3):575-83. PubMed ID: 11872614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.
    Stefani A; Lozano AM; Peppe A; Stanzione P; Galati S; Tropepi D; Pierantozzi M; Brusa L; Scarnati E; Mazzone P
    Brain; 2007 Jun; 130(Pt 6):1596-607. PubMed ID: 17251240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
    Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
    Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease.
    Maurer C; Mergner T; Xie J; Faist M; Pollak P; Lücking CH
    Brain; 2003 May; 126(Pt 5):1146-63. PubMed ID: 12690054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bilateral subthalamic nucleus stimulation on parkinsonian gait.
    Xie J; Krack P; Benabid AL; Pollak P
    J Neurol; 2001 Dec; 248(12):1068-72. PubMed ID: 12013584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease.
    Moro E; Scerrati M; Romito LM; Roselli R; Tonali P; Albanese A
    Neurology; 1999 Jul; 53(1):85-90. PubMed ID: 10408541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral subthalamic nucleus stimulation for Parkinson's disease.
    Doshi PK; Chhaya NA; Bhatt MA
    Neurol India; 2003 Mar; 51(1):43-8. PubMed ID: 12865514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation.
    Moro E; Esselink RJ; Benabid AL; Pollak P
    Brain; 2002 Nov; 125(Pt 11):2408-17. PubMed ID: 12390968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease.
    Molinuevo JL; Valldeoriola F; Tolosa E; Rumia J; Valls-Sole J; Roldan H; Ferrer E
    Arch Neurol; 2000 Jul; 57(7):983-8. PubMed ID: 10891980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation.
    Rodriguez-Oroz MC; Zamarbide I; Guridi J; Palmero MR; Obeso JA
    J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1382-5. PubMed ID: 15377681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral subthalamic stimulation monotherapy in advanced Parkinson's disease: long-term follow-up of patients.
    Valldeoriola F; Pilleri M; Tolosa E; Molinuevo JL; Rumià J; Ferrer E
    Mov Disord; 2002 Jan; 17(1):125-32. PubMed ID: 11835449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Krack P; Batir A; Van Blercom N; Chabardes S; Fraix V; Ardouin C; Koudsie A; Limousin PD; Benazzouz A; LeBas JF; Benabid AL; Pollak P
    N Engl J Med; 2003 Nov; 349(20):1925-34. PubMed ID: 14614167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up.
    Schüpbach WM; Chastan N; Welter ML; Houeto JL; Mesnage V; Bonnet AM; Czernecki V; Maltête D; Hartmann A; Mallet L; Pidoux B; Dormont D; Navarro S; Cornu P; Mallet A; Agid Y
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1640-4. PubMed ID: 16291886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.